REDUCE-IT Trial Studying Icosapent Ethyl: An In-Depth Review of USA Dataset with Commentary - a podcast by ReachMD

CME credits: 0.50

Valid until: 27-02-2021

Claim your CME credit at https://reachmd.com/programs/cme/reduce-it-trial-studying-icosapent-ethyl-an-in-depth-review-of-usa-dataset-with-commentary/11163/

Join an internationally recognized panel of experts as they provide a comprehensive review and commentary of the results from the REDUCE-IT trial, which studied the effect of icosapent ethyl on cardiovascular outcomes. The expert panel also offers insights and pearls on how these results affect clinical lipid management in patients at risk for ASCVD, especially after the FDA expanded the indication of icosapent ethyl to include the reduction of ASCVD events.

Time	Topic	Format
16 minutes	REDUCE-IT USA Subgroup Analysis Deepak L. Bhatt, MD	Audio over slides
7 minutes	Panel Discussion 1 and Q&A	Audio
8 minutes	Panel Discussion 2	Video

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD